Publication
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
Journal Paper/Review - Jun 17, 2016
von Minckwitz G, Jackisch C, Kümmel S, Fasching P A, Schneeweiss A, Paepke S, Untch M, Burchardi N, Mehta K, Loibl S, Hanusch C, Denkert C, Rezai M, Tesch H, Huober Jens, Gerber B, Zahm D M, Hilfrich J, Costa S D, Dubsky P, Blohmer J U, German Breast Group and Austrian Breast and Colon Cancer Study Group Investigators
von Minckwitz, G
14
0
Rezai, M
6
0
Tesch, H
9
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
298
12
Gerber, B
9
0
Zahm, D M
1
0
Hilfrich, J
4
0
Costa, S D
4
0
Dubsky, P
13
0
Blohmer, J U
5
0
Denkert, C
15
0
Hanusch, C
9
0
Jackisch, C
17
0
Kümmel, S
6
0
Fasching, P A
14
0
Schneeweiss, A
14
0
Paepke, S
4
0
Untch, M
19
0
Burchardi, N
6
0
Mehta, K
3
0